FDA Orange Book · active-ingredient family
Metyrosine
Metyrosine is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DEMSER · NDA 017871
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DEMSERRLD | BAUSCH | NDA 017871 | AB | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| METYROSINE | DR REDDYS LABS SA | ANDA 218620 | AB | Apr 09, 2025 | |
| METYROSINE | LEADING | ANDA 215541 | AB | Sep 17, 2024 | |
| METYROSINE | AMNEAL | ANDA 213734 | AB | Jul 24, 2020 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Metyrosine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

